Abstract
Pretreatment plasma ratios of tryptophan (Trp) and tyrosine (Tyr) to other large neutral amino acids were determined in 27 depressed patients who completed a double-blind trial of citalopram, a selective serotonin uptake inhibitor, against maprotiline, a selective noradrenaline uptake inhibitor.
The Trp ratio and the Tyr ratio were decreased in the total patient sample as compared with healthy controls. Plasma Tyr ratio was normal in the endogenous, but significantly decreased in the non-endogenous depressives. There was no significant relationship between the plasma Trp ratio and the probenecid-induced accumulation of 5-HIAA in the CSF, or between the plasma Tyr ratio and HVA level in CSF, whereas the CSF level of MHPG correlated significantly with the plasma Tyr ratio.
There was a significantly positive correlation between the Trp ratio, the Tyr ratio, their sum and the final Hamilton depression score in 14 patients treated with citalopram; on the whole, this association was evident also in the endogenous and non-endogenous subgroups. In 13 patients on maprotiline there was a significantly positive correlation between the plasma Tyr ratio and the percent reduction of Hamilton depression score; this association was poor in the endogenous, whereas a trend towards a correlation remained in the non-endogenous subgroup. The results suggest that the plasma Trp and Tyr ratios may be determinants of clinical improvement in depressed patients to treatment with citalopram and maprotiline. However, further studies are needed on larger patient samples to allow a firm conclusion.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders (DSM-III). American Psychiatric Association, Washington DC
Carney MWP, Roth M, Garside RF (1965) The diagnosis of depressive syndromes and the prediction of E.C.T. response. Br J Psychiatry III:659–674
De Myer MK, Shea PA, Hendrie HC, Yoshimura NN (1981) Plasma tryptophan and five other amino acids in depressed and normal subjects. Arch Gen Psychiatry 38:642–646
Dunlop SR, Hendrie HC, Shea PA, Brittain HM (1983) Ratio of plasma tryptophan to five other amino acids in depressed subjects: a follow-up. Arch Gen Psychiatry 40:1033–1034
Faull KF, Kraemer HC, Barchas JD, Berger PA (1981) Clinical application of the probenecid test for measurement of monoamine turnover in the CNS. Biol Psychiatry 16:879–899
Fernstrom JD, Faller DV (1978) Neutral amino acids in the brain: changes in response to food ingestion. J Neurochem 30:1531–1538
Fernstrom JD, Larin F, Wurtman RJ (1973) Correlations between brain tryptophan and plasma neutral amino acid levels following food consumption in rats. Life Sci 13:517–524
Fernstrom JD, Wurtman RJ (1972) Brain serotonin content: physiological regulation by plasma neutral amino acids. Science 178:414–416
Freedman DX, Belendiuk K, Belendiuk GW, Crayton JW (1981) Blood tryptophan metabolism in chronic schizophrenics. Arch Gen Psychiatry 38:655–659
Gibson CJ, Wurtman RJ (1977) Physiological control of brain catechol synthesis by brain tyrosine concentration. Biochem Pharmacol 26:1137–1142
Hagenfeldt L, Bjerkenstedt L, Edman G, Sedvall G, Wiesel F-A (1984) Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects. J Neurochem 42:833–837
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
Hyttel J (1982) Citalopram — pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatry 6:277–295
Joseph MS, Brewerton TD, Reus VI, Stebbins GT (1984) Plasma l-tryptophan/neutral amino acid ratio and dexamethasone suppression in depression. Psychiatr Res 11:185–192
Møller SE (1977) Quantitative determination of branched-chain and aromatic amino acids by ion-exchange chromatography. Anal Biochem 79:590–593
Møller SE, Honoré P, Larsen OB (1983) Tryptophan and tyrosine ratios to neutral amino acids in endogenous depression: relation to antidepressant response to amitriptyline and lithium + l-tryptophan. J Affect Dis 5:67–79
Møller SE, Kirk L, Honoré P (1980) Relationship between plasma ratio of tryptophan to competing amino acids and the response to l-tryptophan treatment in endogenously depressed patients. J Affect Dis 2:47–59
Møller SE, Reisby N, Ortmann J, Elley J, Krautwald O (1981) Relevance of tryptophan and tyrosine availability in endogenous and “non-endogenous” depressives treated with imipramine or clomipramine. J Affect Dis 3:231–244
Møller SE, Ødum K, Kirk L, Bjerre M, Fog-Møller F, Knudsen A (1985) Plasma tyrosine/neutral amino acid ratio correlated with clinical response to nortriptyline in endogenously depressed patients. J Affect Dis (in press)
Pardridge WM (1977) Kinetics of competitive inhibition of neutral amino acid transport across the blood-brain barrier. J Neurochem 28:103–108
van Praag HM, Korf J (1974) Serotonin metabolism in depression: clinical application of the probenecid test. Int Pharmacopsychiatr 9:35–51
Siegel S (1956) Nonparametric Statistics for the Behavioral Sciences, McGraw-Hill, New York
Yuwiler A, Oldendorf WH, Geller E, Braun L (1977) Effect of albumin binding and amino acid competition on tryptophan uptake into brain. J Neurochem 28:1015–1023
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Møller, S.E., de Beurs, P., Timmerman, L. et al. Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline. Psychopharmacologia 88, 96–100 (1986). https://doi.org/10.1007/BF00310520
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00310520